ARCHIVES

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Grant Review: NIH Names Members To New Clinical Oncology Review Panel

February 26, 1999

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

Clearinghouse Finds Five Compounds Pose Risk To Humans

March 2, 1979

FDA Approves HPV Test

April 25, 2003

OMB Caused The Problem But Did Not Order Transfer Of $20 Million From Centers Program to Grants Poll

April 29, 1983

Evidence “Weak” Linking EMFs, cancer

June 25, 1999